Mando

Privacy And Cross-Chain

Privacy and quantum-resistance narratives are drawing attention as investors favor a small set of leading altcoin stories over speculative memes. The key risk is that bullish calls remain sentiment- and momentum-driven.

• ZEC: Seen as a potential major re-rating toward $100B+, with a favorable retest and renewed buying cited.
• NEAR: Bitwise targets $155 in its base case and $562 bull case; a local move toward $3–$3.50 is also anticipated. NRR stakes NEAR and retains about 67% of rewards.

Trading And Market Structure

Commentary favors a near-term risk-on move, but also warns of a pullback after leverage and altcoin positioning build. Price targets are forecasts, not guarantees.

• BTC: Some expect $90K as the next major target; another view sees a failed $88K reclaim and retest near $80K. A move to $81K–$82K was also anticipated.
• HYPE: Bullish chart setup near an ATH breakout, with a Kraken deal and innovation exemption cited as catalysts; targets cluster at $100–$130.
• SOL: Its disinflation proposal passed after nearly two years of debate, a potentially meaningful tokenomics development.

Crypto And Equities

Beyond leading tokens, sources point to selective protocol economics and company-specific catalysts, while emphasizing active profit-taking in fast-moving market themes.

• HOOD: Bullish call targets $180 by Q3 earnings, citing Robinhood Chain record daily fees of $6M, weekly fees of $25M, and DEX volume of $12.4B.
• PONS: Described as potentially mispriced near a $25M market cap; reported burns, buybacks, and fee share could support repricing if revenue persists.
• LLY: A favorable Seventh Circuit decision on retatrutide’s biological-product status could extend patent protection; oral arguments were scheduled for September 24, 2026.